DURECT Corporation, a leading biopharmaceutical company based in the United States, focuses on developing innovative therapeutics for chronic diseases and pain management. Founded in 1998, DURECT has made significant strides in the industry, particularly with its proprietary drug delivery technologies and formulations. Headquartered in Cupertino, California, the company operates primarily in the biopharmaceutical sector, specialising in long-acting injectable products and novel drug delivery systems. DURECT's core offerings, such as its DUR-928 and the SABER® technology platform, stand out for their potential to enhance patient outcomes through improved efficacy and reduced side effects. With a strong market position, DURECT has garnered attention for its commitment to advancing healthcare solutions, making it a notable player in the biopharmaceutical landscape.
How does DURECT Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
DURECT Corporation's score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
DURECT Corporation, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that DURECT Corporation may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, DURECT Corporation's future climate commitments will be crucial for aligning with broader environmental goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
DURECT Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

